Gelonghui October 14th | tianshui zhongxing bio-technology (002772.SZ) stated on the investor interaction platform that the winter cordyceps industrial production project implemented by Tianjin Jinxing Bio-technology Co., Ltd., a joint venture of the company, has gradually been listed for sale, but the project scale is small and the company's wholly-owned subsidiary Zhongan Bio-technology holds 51% of its equity, so the short-term impact on the company is relatively small. Currently, the company's products like enoki mushrooms, shiitake mushrooms, and northern cordyceps are all sold as fresh products.
众兴菌业(002772.SZ)：目前公司的产品金针菇、双胞菇、北虫草均是鲜品销售
tianshui zhongxing bio-technology (002772.SZ): Currently, the company's products such as needle mushroom, shimeji mushroom, and beichong grass are all sold as fresh products.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.